Mellar Davis | Pharmacology | Best Researcher Award

Published on 05/03/202505/03/2025 by Forensic Scientist

Prof. Dr. Mellar Davis | Pharmacology | Best Researcher Award

MD FCCP FAAHPM | Levine Cancer Institute | United States

Dr. Mellar Pilgrim Davis, MD, FCCP, FAAHPM, is a distinguished physician specializing in oncology, hematology, and palliative medicine. With decades of experience in clinical practice, research, and education, he has made significant contributions to supportive cancer care. Dr. Davis has held key academic and clinical positions at renowned institutions, impacting patient care and medical education worldwide.

Profile👤

Scopus

Strengths for the Awards✨

Extensive Research and Publications 📚
- Dr. Davis has a prolific research career, with significant contributions in oncology, palliative care, and pain management.
- Recognized as a World Expert in Analgesics (Top 0.1% of scholars per Expertscape).
- Highly ranked in Symptomatic Treatment (#4) and Palliative Care (#21) by ScholarGPS.
Significant Impact in Palliative Medicine 🌿
- Held leadership roles in the Multinational Association of Supportive Care in Cancer (MASCC), including Chair of the Pain Subgroup.
- Developed guidelines and educational programs for pain and opioid management in cancer care.
- Recognized for outstanding contributions to cancer pain management by MD Anderson Cancer Center (2023).
Recognized Excellence in Teaching and Mentorship 🎓
- Multiple Teacher of the Year awards in Cleveland Clinic and Geisinger.
- Full Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine.
Leadership and Professional Influence 🌍
- Served on NCI, ASCO, ACS, and NCCN panels, shaping research and clinical practice in oncology and palliative care.
- Co-Chair of the International Conference on Opioids, advancing pain research.

Education🎓

Dr. Davis earned his Bachelor of Science degree from Otterbein College in 1974 and his MD from Ohio State Medical College in 1977. He further honed his expertise through rigorous postdoctoral training, including an Internal Medicine residency at Riverside Methodist Hospital and a Hematology/Oncology fellowship at Mayo Clinic.

Experience👩‍⚕️

Over the years, Dr. Davis has served in various prestigious medical institutions. His career journey includes roles at Toledo Clinic, Milhon Clinic, Columbus Oncology Associates, Cleveland Clinic, and Geisinger Medical Center. Additionally, he has held academic appointments as a Professor of Medicine at Cleveland Clinic Lerner School of Medicine and as a Professor of Palliative Medicine at Geisinger Commonwealth School of Medicine

Research Interests On Pharmacology

📝 Dr. Davis’s research focuses on palliative medicine, oncology symptom management, pain control, and ethical issues in cancer care. His work has influenced medical guidelines and practices worldwide, especially in the fields of palliative care and supportive oncology.

Awards and Honors🏆

Dr. Davis has received numerous awards, including the Compassion in Medicine Award, multiple “Best Doctors in America” recognitions, and the Distinguished Service Award from the Multinational Association of Supportive Care in Cancer. He has also been acknowledged as a world expert in analgesics and palliative care.

Publications📚

Are Muscle and Fat Loss Predictive of Clinical Events in Pancreatic Cancer? The Importance of Precision Metrics
- Authors: M.P. Davis, N. Bader, J.L. Basting, B. Lagerman, M.J. Wojtowicz
- Publication Year: 2025
Buprenorphine Pharmacodynamics: A Bridge to Understanding Buprenorphine Clinical Benefits
- Authors: M.P. Davis
- Publication Year: 2025
Treatment of Established Chemotherapy-Induced Neuropathy with N-Palmitoylethanolamide: A Randomized, Double-Blind Phase II Pilot Study
- Authors: M.P. Davis, A.M. Ulrich, R. Segal, B.A. Bauer, C.L. Loprinzi
- Publication Year: 2024
Respiratory Depression Associated with Opioids: A Narrative Review
- Authors: M.P. Davis, S.L. DiScala, A. Davis
- Publication Year: 2024
The Surprise Question: Not Ready for Prime Time
- Authors: M.P. Davis
- Publication Year: 2024
Correction to: Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline
- Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
- Publication Year: 2024
Understanding The Number Needed to Treat
- Authors: M.P. Davis, E.A. Vanenkevort
- Publication Year: 2024
Opioid Analgesic Dose and Route Conversion Ratio Studies: A Scoping Review to Inform an eDelphi Guideline
- Authors: M.P. Davis, A.N. Davies, M.L. McPherson, E.D. Bruera, C.I. Ripamonti
- Publication Year: 2024
Fentanyl Pharmacokinetic Paradoxical in Cancer Cachexia
- Authors: M.P. Davis
- Publication Year: 2024

Conclusion🎯

Dr. Mellar Pilgrim Davis has dedicated his career to improving cancer care and palliative medicine. Through his extensive research, clinical expertise, and commitment to education, he has left an enduring impact on patient care and medical knowledge. His legacy continues to inspire healthcare professionals worldwide.

Marlin Touma | Genetics | Best Researcher Award

Published on 01/03/202501/03/2025 by Forensic Scientist

Prof. Dr. Marlin Touma | Genetics | Best Researcher Award

Faculty | UCLA – David Geffen School of Medicine | United States

Dr. Marlin Touma is an esteemed physician-scientist specializing in neonatal-perinatal medicine, congenital heart defects, and cardiovascular research. She currently serves as an Associate Professor-in-Residence at the David Geffen School of Medicine, UCLA. With extensive experience in both clinical and research settings, Dr. Touma has contributed significantly to understanding congenital heart disease, neonatal cardiovascular development, and regenerative medicine. She is the Director of the UCLA Congenital Heart Defects Research Program and the UCLA Congenital Heart Defects-BioCore.

Profile👤

Google Scholar

ORCID

Scopus

Strengths for the Awards✨

Extensive Research and Leadership
- Founder and Principal Investigator of the UCLA Congenital Heart Defects-BioCore since 2013.
- Director of the UCLA Congenital Heart Defects Research Program since 2020.
- Multiple leadership roles at David Geffen School of Medicine at UCLA.
Significant Contributions to Cardiovascular Research
- Ph.D. in Molecular, Cellular & Integrative Physiology from UCLA.
- Research on genetics and genomics of congenital heart defects, a critical area in neonatal-perinatal medicine.
- Involvement in NIH research programs and review panels, demonstrating national recognition.
Recognition and Awards
- Outstanding Research Award (Mead Johnson, 2011, American Academy of Pediatrics).
- Finalist Award (2021 Mid-Career Research Scholar Award, International Society for Heart Research).
- Multiple invited speaker and session chair roles at AHA, ISHR, and UCLA cardiovascular symposia.
- Travel and research awards from AHA, NIH, and other prestigious institutions.
Educational and Clinical Excellence
- Trained at Harvard Medical School, UCLA, and Damascus University.
- Board-certified in General Pediatrics and Neonatal-Perinatal Medicine.
- Director of programs that integrate cutting-edge research with clinical applications.

🎓 Education

M.D. (1992) – Damascus University School of Medicine, Syria
Pediatrics Residency (1992-1996) – Children’s Hospital of Damascus University, Syria
Senior Pediatric Residency (1995-1996) – Children’s Hospital of Damascus University, Syria
Master’s Degree (Postgraduate Diploma) (1997) – Damascus University, Syria
Pediatrics Residency (2005-2008) – Dell Children’s Medical Center, University of Texas Medical Branch, USA
Neonatal-Perinatal Medicine Fellowship (2008-2011) – Harvard Medical School, USA
Ph.D. in Molecular, Cellular & Integrative Physiology (2015) – University of California, Los Angeles (UCLA), USA

💼 Experience

Current Positions:
- Associate Professor-in-Residence, Department of Pediatrics, UCLA
- Director, UCLA Congenital Heart Defects-BioCore
- Director, UCLA Congenital Heart Defects Research Program
Previous Positions:
- Clinical Instructor in Pediatrics, UCLA (2011-2014)
- Assistant Professor-in-Residence, UCLA (2014-2021)
- Fellow in Neonatology, Harvard Medical School (2008-2011)
- Pediatric Resident, Dell Children’s Medical Center, University of Texas Medical Branch (2005-2008)
- Senior Pediatrician, Al Obaid General Hospital, Saudi Arabia (2000-2002)

📝 Research Interests On Genetics

Dr. Touma’s research focuses on congenital heart defects, neonatal cardiovascular development, and gene-environment interactions in heart disease. She is particularly interested in molecular mechanisms regulating heart development, regenerative therapies, and translational approaches to improve pediatric cardiovascular health.

🏆 Awards & Honors

Award for Excellence (Top Ten Students in Country) – Syrian Ministry of Higher Education
Best Resident in Pediatrics Award – Damascus University
Outstanding Research Award – American Academy of Pediatrics National Conference (2011)
UCLA STAR Award for Doctoral Scholarship Admission (2011)
Finalist Award – Mid-Career Research Scholar Award – International Society for Heart Research (2021)
International Abstract Travel Award – International Society for Heart Research (2022)
Distinguished Speaker & Session Chair – Multiple conferences, including AHA and ISHR

📚 Publications

Dr. Touma has authored numerous research articles in high-impact journals. Some selected publications include:

Repression of Sox9 by Jag1 is continuously required to suppress the default chondrogenic fate of vascular smooth muscle cells
- Authors: A Briot, A Jaroszewicz, CM Warren, J Lu, M Touma, C Rudat, JJ Hofmann, …
- Year: 2014
- Citations: 81
COVID-19: molecular diagnostics overview
- Author: M Touma
- Year: 2020
- Citations: 76
Nkx2-5 suppresses the proliferation of atrial myocytes and conduction system
- Authors: Y Nakashima, DA Yanez, M Touma, H Nakano, A Jaroszewicz, …
- Year: 2014
- Citations: 68
Whole genome sequencing identifies SCN2A mutation in monozygotic twins with Ohtahara syndrome and unique neuropathologic findings
- Authors: M Touma, M Joshi, MC Connolly, P Ellen Grant, AR Hansen, O Khwaja, …
- Year: 2013
- Citations: 63
Decoding the long noncoding RNA during cardiac maturation: a roadmap for functional discovery
- Authors: M Touma, X Kang, Y Zhao, AA Cass, F Gao, R Biniwale, G Coppola, …
- Year: 2016
- Citations: 48
Improved pulmonary vascular reactivity and decreased hypertrophic remodeling during nonhypercapnic acidosis in experimental pulmonary hypertension
- Authors: H Christou, OM Reslan, V Mam, AF Tanbe, SH Vitali, M Touma, E Arons, …
- Year: 2012
- Citations: 38
Ppp1r1b-lncRNA inhibits PRC2 at myogenic regulatory genes to promote cardiac and skeletal muscle development in mouse and human
- Authors: X Kang, Y Zhao, G Van Arsdell, SF Nelson, M Touma
- Year: 2020
- Citations: 36
p38 Mitogen-activated protein kinase regulates chamber-specific perinatal growth in heart
- Authors: T Yokota, J Li, J Huang, Z Xiong, Q Zhang, T Chan, Y Ding, C Rau, …
- Year: 2020
- Citations: 34
Maternal calorie restriction causing uteroplacental insufficiency differentially affects mammalian placental glucose and leucine transport molecular mechanisms
- Authors: A Ganguly, M Touma, S Thamotharan, DC De Vivo, SU Devaskar
- Year: 2016
- Citations: 30
Wnt11 regulates cardiac chamber development and disease during perinatal maturation
- Authors: M Touma, X Kang, F Gao, Y Zhao, AA Cass, R Biniwale, X Xiao, …
- Year: 2017
- Citations: 27
Echocardiographic markers of pulmonary hemodynamics and right ventricular hypertrophy in rat models of pulmonary hypertension
- Authors: F Spyropoulos, SH Vitali, M Touma, CD Rose, CR Petty, P Levy, …
- Year: 2020
- Citations: 23
A path to implement precision child health cardiovascular medicine
- Authors: M Touma, B Reemtsen, N Halnon, J Alejos, JP Finn, SF Nelson, Y Wang
- Year: 2017
- Citations: 17

📄 Conclusion

Dr. Marlin Touma is a renowned expert in neonatal cardiovascular research with an impressive track record of clinical excellence, academic achievements, and innovative research. As a leading scientist in congenital heart defects and pediatric cardiology, her work continues to shape the future of neonatal medicine and cardiovascular health worldwide.

Silvia Di Bonaventura | Neuroscience | Women Researcher Award

Published on 01/03/202501/03/2025 by Forensic Scientist

Ms. Silvia Di Bonaventura | Neuroscience | Women Researcher Award

Audiologist | University College London Hospitals NHS Foundation Trust | United Kingdom

Ms. Silvia, A dedicated Clinical and Research Audiologist at University College London (UCL) with extensive experience in audiology, hearing loss management, and auditory processing disorders. With a strong academic background and significant contributions to research, this professional has played a crucial role in national health initiatives and audiological advancements.

Profile👤

ORCID

Strengths for the Awards✨

Academic Excellence 🎓
- Holds a Master of Science in Advanced Audiology (with Merit) from University College London (UCL), one of the world’s top institutions.
- Additional Master’s degree in Autism Spectrum Disorders (with Distinction).
- Bachelor’s degree in Audiology with First Class Honours from University of Padua.
Significant Research Contributions 🔬
- Key researcher in the SeaSHeL study, the largest UK cohort study on sudden sensorineural hearing loss, involving over 100 NHS hospitals.
- Published work in BMJ Open and other platforms, contributing to the advancement of clinical audiology research.
- Involvement in research and clinical guidelines development through the British Society of Audiology (BSA) and National Institute for Health and Care Excellence (NICE).
Extensive Professional Experience in Audiology & Research 👩‍⚕️
- Senior Audiologist at UCL Hospitals NHS Foundation Trust, specializing in pediatric and advanced audiological assessments.
- Expertise in Auditory Processing Disorders (APD), vestibular testing, and hearing aid rehabilitation.
- Former Adjunct Professor at the University of Pisa, teaching audiological testing and hearing aid fitting.

Education 🎓

Master of Science in Advanced Audiology (2020-2022) – University College London (UK)
- Obtained with Merit
- Thesis: “The impact of idiopathic sudden sensorineural hearing loss on patients’ quality of life”
Master in Autism Spectrum Disorders and Communication Disorders (2020) – University “Niccolò Cusano” (Italy)
- Obtained with Distinction
- Thesis: “Autism and hearing loss: management of two contrasting case studies”
Bachelor of Science in Audiology (2014-2017) – University of Padua (Italy)
- Obtained with First Class Honours
- Thesis: “Evaluating aided hearing performance and functional gain in case studies: a comparison between Italy and Spain”

Experience 🌍

Senior Audiologist (2021-Present) – Royal National ENT and Eastman Dental Hospital, University College London Hospitals NHS Foundation Trust
- Performing advanced audiological assessments in pediatric patients
- Developing clinical protocols and monitoring adherence to best practices
- Diagnosing and managing Auditory Processing Disorders (APD)
- Leading pediatric aural rehabilitation with hearing aids and BAHA devices
Researcher & Member of the Central Academic Team for the SeaSHeL Study (2020-Present) – National Institute for Health Research (NIHR), London, UK
- Coordinating the largest UK cohort study on sudden sensorineural hearing loss
- Managing research across over 100 NHS hospitals
- Website: SeaSHeL Study
Adjunct Professor (2023) – University of Pisa (Italy)
- Teaching modules on audiometry, audiological tests, and hearing aid optimization
Clinical Roles in Audiology (2017-Present)
- Paediatric Audiologist – Barts Health NHS Trust (2020-2021)
- Audiologist – James Paget University Hospitals NHS Foundation Trust (2019)
- Clinical Placement – Ospedale Civile “Santo Spirito,” Pescara & Treviso Regional Hospitals (2015-2016)

Research Interests On Neuroscience

Auditory Processing Disorders (APD) and its clinical management
Hearing loss and rehabilitation strategies in pediatric populations
Sudden sensorineural hearing loss and its impact on quality of life
Integration of audiology within autism spectrum disorder care

Awards 🏆

Erasmus+ Traineeship Winner (2017) – Funded internship in Madrid, Spain, working across five Amplifon hearing centers
Professional Certifications:
- Certified Ear Microsuction Specialist (2022) – Clear Earwax, London, UK
- Multiple membership certifications in audiology societies

Publications 📚

“The impact of idiopathic sudden sensorineural hearing loss on patients’ quality of life” (2022) – Published in BMJ Open
- Read here
“Evaluating aided hearing performance and functional gain in case studies: a comparison between Italy and Spain” (2017) – Published in Journal of Audiological Research

Conclusion 🎯

A passionate audiology professional committed to research, clinical excellence, and improving patient outcomes. With a strong foundation in education and an active role in leading audiology initiatives, this expert continues to drive innovation in hearing healthcare.

Mei-Lang Kung | Pharmacology | Women Researcher Award

Published on 01/03/202501/03/2025 by Forensic Scientist

Assist. Prof. Dr. Mei-Lang Kung | Pharmacology | Women Researcher Award

Senior Assistant Research Fellow | Kaohsiung Veterans General Hospital | Taiwan

Dr. Mei-Lang Kung is a distinguished researcher and academic specializing in cancer biology, gene engineering, and phytochemical pharmacology. She currently serves as a Senior Assistant Research Fellow at the Department of Medical Education and Research, Kaohsiung Veterans General Hospital, and an Assistant Professor at Shu-Zen Junior College of Medicine and Management. With a strong background in molecular biology and nanomedicine, Dr. Kung has contributed significantly to innovative research in oncology and nanomaterials for medical applications.

Profile👤

ORCID

Scopus

Strengths for the Awards✨

Strong Academic Background 📚
- Dr. Mei-Lang Kung holds a Ph.D. in Biological Science from National Sun Yat-sen University (2012).
- Her dissertation focused on cancer cell migration and epithelial-mesenchymal transition, a highly relevant area in biomedical research.
Extensive Research Expertise 🔬
- Her work spans multiple interdisciplinary fields, including cancer biology, gene engineering, phytochemical pharmacology, and green nanomaterials.
- These diverse skill sets enhance the impact of her research in translational medicine.
Significant Research Contributions 🏆
- 21+ peer-reviewed publications in high-impact journals (SCI-indexed).
- Notable research on nanomedicine and cancer treatment strategies, contributing to innovative therapeutic approaches.
- Demonstrated leadership as a corresponding author in multiple studies, reflecting independent research capability.
Recognition & Awards 🥇
- Best Poster Award (2021) from the Taiwan Urology Association.
- National Taiwan University System Young Scholars Award (2018) for innovative research.
- Multiple Outstanding Paper Awards at prestigious conferences (IEEE, New Advance in Medicine, etc.).
- These accolades highlight her excellence in research and scholarly impact.

Education 🎓

Dr. Kung earned her Ph.D. in Biological Science from National Sun Yat-sen University, Kaohsiung, Taiwan, in 2012, under the guidance of Prof. Tai Ming-Hong. Her dissertation focused on the mechanisms of hepatoma-derived growth factor-mediated cell migration and epithelial-mesenchymal transition. She also holds an M.S. in Biochemistry from Kaohsiung Medical University (2002) and a B.S. in Nutrition from Chung Shan Medical University (2000).

Experience 🌟

Dr. Kung has extensive experience in academia and research. Since 2019, she has been a Senior Assistant Research Fellow at Kaohsiung Veterans General Hospital. She also holds a faculty position at Shu-Zen Junior College of Medicine and Management. Previously, she served as an Assistant Faculty member (2017-2019) and a Postdoctoral Research Associate (2012-2017) in the Chemistry Department of National Sun Yat-sen University, working under Dr. Shuchen Hsieh.

Research Interests On Pharmacology 📚

Dr. Kung’s research interests include cancer biology, gene engineering, phytochemical pharmacology, and toxicology. She is particularly focused on the development and applications of green nanomaterials for cancer treatment. Her work explores novel phytochemically derived nanoparticles and their effects on cancer cell adhesion, proliferation, and metastasis.

Awards 🏆

2021: Taiwan Urology Association “Best Academic Activity Award – Best Poster Award”
2018: National Taiwan University System Young Scholars Selection for Innovative Research and Development Achievements – Excellent Work Award
2015: New Advance in Generation Medicine, Cancer and Stem Cell Outstanding Paper Award
2013: IEEE Nanotechnology Materials and Devices Conference, Outstanding Paper Award

Publications 📰

Dr. Kung has authored numerous peer-reviewed publications in high-impact journals. Below are some of her notable works:

Wang, J.-H., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2025). “Nanosized ginger-derived phenolic zingerone obstructs cell cycle G2/M progression and initiates apoptosis in human colorectal cancer.” Environmental Toxicology. DOI:10.1002/tox.24470 (SCI; 2023 IF=4.4)
Chu, L.-W., Chen, J.-Y., Chen, Y.-W., Hsieh, S., & Kung, M.-L.* (2024). “Phytoconstituent-derived zingerone nanoparticles disrupt cell adhesion and suppress cell motility in melanoma B16F10 cells.” Journal of Biotechnology. DOI:10.1016/j.jbiotec.2024.06.015
Kung, M.-L., Cheng, S. M., Wang, Y.-H., et al.* (2024). “Deficiency of RNA adenosine deaminase (ADAR2) ameliorates metabolic-associated fatty liver disease via AMPK signaling pathways in male diet-induced obese mice.” Communications Biology. (SCI; 2022 IF=5.9)
Kung, M.-L., Yang, T.-H., Lin, C.-C., et al.* (2024). “ADAR2 deficiency ameliorates nonalcoholic fatty liver disease and muscle atrophy through modulating serum amyloid A1.” Journal of Cachexia, Sarcopenia and Muscle. DOI:10.1002/jcsm.13460 (SCI; 2022 IF=8.9)
Hu, T.-H., Wu, J.-C., Huang, S.-T., et al.* (2023). “HDGF Stimulates Liver Tumorigenesis by Enhancing Reactive Oxygen Species Generation in Mitochondria.” Journal of Biological Chemistry. (SCI; 2022 IF=4.8)

Conclusion 📚

Dr. Mei-Lang Kung has made remarkable contributions to cancer research and nanomedicine, with a strong emphasis on translating scientific discoveries into therapeutic applications. Her expertise in molecular oncology and green nanotechnology continues to impact the scientific community, making her a leader in the field of biomedical research. Through her innovative work, she strives to advance cancer treatment strategies and improve patient outcomes.

Joshua Chang | Management | Best Researcher Award

Published on 01/03/202501/03/2025 by Forensic Scientist

Assoc. Prof. Dr. Joshua Chang | Management | Best Researcher Award

ChienKuo Technology University | Taiwan

Joshua Chang is a distinguished scholar and academic leader with over 20 years of experience in higher education, academic administration, and business leadership. Currently serving as the Chair of the Department of International Business Administration and Director of the Graduate School of Services & Technology Management at ChienKuo Technology University, he has made significant contributions to business intelligence, e-commerce, and strategic management. As the founding director of the Center for Knowledge Innovation and Poll, Joshua has played a pivotal role in integrating IT applications into business and marketing strategies. His contributions extend beyond academia, having co-founded an international food company and authored five influential books.

Profile👤

ORCID

Strengths for the Awards✨

Extensive Research & Publications 📚
- Over 50 published works, including 9 journal articles in recognized databases like SCI and Scopus.
- Authored 5 books covering business intelligence, knowledge management, and marketing.
- Holds one patent, demonstrating research innovation.
- Completed 14 research projects and contributed to 7 industry consultancy projects.
Academic Leadership & Editorial Contributions 🏆
- Serves as Chair of the Department of International Business Administration at ChienKuo Technology University.
- Holds multiple editorial roles in prestigious journals and is an active peer reviewer for various international conferences and journals.
Interdisciplinary Expertise 🔬
- His work integrates business intelligence, strategic management, knowledge innovation, and e-commerce, making him a versatile researcher.
- Contributions to storytelling marketing, consumer behavior, and digital transformation add a unique perspective to business research.
International Recognition & Professional Memberships 🌍
- Received the President Award of Taiwan for Distinguished Manager.
- Member of IEEE, Academy of Human Resource Development, and Chinese Society of Information Management, highlighting his global academic presence.
- Co-founded an international food company, showcasing a blend of research and industry expertise.

🎓 Education

Ph.D. in Business Administration – Touro University, USA (2003)
Master in Computer-Based Education – California State University, USA (2000)

💼 Experience

Chair & Director, ChienKuo Technology University (2025–Present)
Associate Professor, Dept. of Marketing & Service Management (2023–Present)
Assistant Professor, Dept. of Marketing & Service Management (2014–Present)
Assistant Professor, Dept. of Management Information System (2000–Present)
Director, Knowledge Innovation and Poll Center (2008–Present)
Expert Professor, Dept. of Science and Law, Academy of Promoting Economic Legislation (2011–Present)
Co-Professor, College of International Management, National Jinan University, China (2011–2014)
Legislative Consultant, Taiwan Legislative Yuan (2002–2005)
Director, Master of Science in International Administration, University of La Verne, USA (1997–2000)
Senior Manager in Marketing, High Mountain International Food Company (1992–1997)
Senior Consultant, Ladder International English Company (1991–1992)
Financial Planner, Arcadia Institute & Culture Center, USA (1988–1991)

🔬 Research Interests On Management

Joshua’s research focuses on business intelligence, knowledge management, and strategic management. His work emphasizes the applications of these disciplines in marketing, organizational development, and public opinion analysis. His studies explore servicescape quality, consumer behavior, and customer satisfaction, particularly in tourism and leisure industries. He has also conducted research on storytelling marketing, brand image, and purchase intention. His expertise extends to e-commerce and data mining for consumer insights, business simulation systems, enterprise digital transformation, and public opinion survey methodologies.

🏆 Awards & Recognitions

President Award of the Republic of China (Taiwan) for Distinguished Manager
IEEE Member (91276662), USA
IEEE Industrial Electronics Society Member (91276662), USA
Academy of Human Resource Development Member (4290), USA
Organizational Behavior Teaching Society Member, USA
Notary Public (EA018270), USA
International Taekwondo Instructor and Referee, USA
Chinese Management Association Senior Member (CMA7341), Taiwan

📚 Publications

Joshua has published over 50 research articles, book chapters, and conference papers. Below are some of his key publications:

The mediating role of brand image in the relationship between storytelling marketing and purchase intention: case study of PX Mart
- Authors: Joshua Chang
- Publication Year: 2025
- Citations: Not available (recent publication)
Constructing a servicescape quality scale for amusement parks in Taiwan
- Authors: Joshua Chang
- Publication Year: 2025
- Citations: Not available (recent publication)
A sustainability perspective: The influence of green marketing on Mongolian consumer attitudes
- Authors: Joshua Chang
- Publication Year: 2024
Performance evaluation for cloud computing applications: A case study of P Company chain store
- Authors: Joshua Chang
- Publication Year: 2023
The impact of servicescape on quality perception and customers’ behavioral intentions
- Authors: Joshua Chang
- Publication Year: 2016
Shifts of communication satisfaction dimensions in the web-based era: A confirmatory study in Taiwan IT industry
- Authors: Joshua Chang
- Publication Year: 2013
Strengthening value innovation potential: A study of innovation-oriented industry in Taiwan
- Authors: Joshua Chang
- Publication Year: 2013

📜 Conclusion

Joshua Chang, Ph.D., is a highly accomplished academic, researcher, and business leader whose contributions span multiple domains, including business intelligence, strategic management, and marketing. His dedication to integrating IT applications into business strategies and his research on consumer behavior have significantly impacted the field. As a mentor, educator, and consultant, he continues to inspire and innovate, making substantial contributions to both academia and industry. His work remains a cornerstone for business excellence and knowledge-driven growth.